found the treatment of Nec-1, an inhibitor of RIPK1, alleviated bone loss in OVX mice, indicating the potential application of Nec-1 in the treatment of postmenopausal osteoporosis (128). The gene discussed is PCSK1; the disease is postmenopausal osteoporosis.